Publiziert in: Marktpuls, Unternehmen
Frei
Alcon - Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS Dienstag, 13. Mai 2025 - 22:31
Ad Hoc Announcement Pursuant to Art. 53 LR
Contact Alcon Investor Relations
+41 589 112 110
+1 817 615 2789
investor.relations@alcon.com
Switzerland: +41 62 205 77 00
U.S. Toll Free: +1 800 736 3001
International: +1 781 575 3100
Investor Email Alerts
|